Vr Adviser, LLC Syndax Pharmaceuticals Inc Transaction History

Vr Adviser, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$13.42 - $25.18 $7.94 Million - $14.9 Million	-591,782 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$19.28 - $24.59 $10.1 Million - $12.9 Million	-523,473 Reduced 46.94%	591,782 $13.2 Million
Q4 2020 Feb 12, 2021	BUY	$15.1 - $26.44 $7.39 Million - $12.9 Million	489,545 Added 78.24%	1,115,255 $24.8 Million
Q2 2020 Aug 14, 2020	BUY	$8.94 - $20.98 $5.59 Million - $13.1 Million	625,710 New	625,710 $9.27 Million

227

88.3M

1.01M

692K

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $902M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

Stay updated on Vr Adviser, LLC with notifications on news.